Focus: Paion is a German-based specialty pharmaceutical company focused on neurology and procedural sedation/anesthesia. The company is publicly traded and operates at mid-stage development with a diversified pipeline across multiple therapeutic indications.
Profile data last refreshed 16h ago · AI intelligence enriched 1w ago
Growing — net +5 jobs in 30d
8 jobs added vs 3 removed. Steady team buildout.
Paion is a promising pipeline-stage company best suited for early-career researchers, regulatory professionals, and risk-tolerant commercial talent willing to build value in exchange for launch upside.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Paion
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Paion's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles